₹275.4
▼ -0.8 -0.29%
17 Jul 2026
NSE Listed
Artemis Med Service Ltd. (ARTEMISMED)
Volume: 1,47,534Avg Vol 1W: 2,39,640.6Avg Vol 1M: 1,73,053.752W Range:₹203.35₹297.5
Key Ratios
Checked 21h agoMarket Cap₹4,372 Cr
Current Price₹275.4
Previous Close₹276.2
High / Low (52w)₹297.5 / ₹203.35
Volume1,47,534
Avg Vol (1W)2,39,640.6
Avg Vol (1M)1,73,053.7
Stock P/E45.26
Book Value₹56.2
Dividend Yield—
ROE14.4%
ROA—
Revenue (TTM)₹970 Cr
Revenue Growth—
Profit Margin—
Total Debt₹209 Cr
Shares Outstanding—
Face Value₹1
EPS (TTM)₹6.07
P/B4.89
Debt / Equity0.51
50 DMA₹268.23
200 DMA₹253.04
Day change-0.29%
Price Chart
₹275.4▲ 9.94% · 1Y
2025-07-162026-07-15
20-day avg volume: 1.7L shares
Pros
- Company is almost debt-free.
- Revenue grew 38% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹223 Cr | ₹241 Cr | ₹232 Cr | ₹240 Cr | ₹255 Cr | ₹275 Cr | ₹272 Cr | ₹279 Cr |
| EBITDA | ₹30 Cr | ₹39 Cr | ₹35 Cr | ₹37 Cr | ₹37 Cr | ₹47 Cr | ₹40 Cr | ₹47 Cr |
| Net Profit | ₹17 Cr | ₹22 Cr | ₹21 Cr | ₹23 Cr | ₹21 Cr | ₹30 Cr | ₹22 Cr | ₹30 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹551 Cr | ₹570 Cr | ₹412 Cr | ₹559 Cr | ₹745 Cr | ₹886 Cr | ₹970 Cr | ₹1,111 Cr |
| EBITDA | ₹48 Cr | ₹43 Cr | ₹17 Cr | ₹49 Cr | ₹70 Cr | ₹100 Cr | ₹140 Cr | ₹170 Cr |
| Net Profit | ₹20 Cr | ₹20 Cr | ₹6 Cr | ₹32 Cr | ₹39 Cr | ₹49 Cr | ₹83 Cr | ₹104 Cr |
| EPS | 15.48 | 14.95 | 4.9 | 2.29 | 2.79 | 3.53 | 5.31 | 6.56 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹554 Cr | ₹586 Cr | ₹600 Cr | ₹710 Cr | ₹905 Cr | ₹972 Cr | ₹1,357 Cr | ₹1,429 Cr |
| Total Liabilities | ₹261 Cr | ₹273 Cr | ₹278 Cr | ₹348 Cr | ₹497 Cr | ₹517 Cr | ₹514 Cr | ₹488 Cr |
| Equity | ₹293 Cr | ₹314 Cr | ₹322 Cr | ₹361 Cr | ₹408 Cr | ₹455 Cr | ₹844 Cr | ₹941 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹50 Cr | ₹60 Cr | ₹29 Cr | ₹43 Cr | ₹130 Cr | ₹124 Cr | ₹170 Cr | ₹149 Cr |
| Investing | ₹-50 Cr | ₹-26 Cr | ₹-37 Cr | ₹-107 Cr | ₹-158 Cr | ₹-88 Cr | ₹-393 Cr | ₹-90 Cr |
| Financing | ₹14 Cr | ₹-27 Cr | ₹18 Cr | ₹44 Cr | ₹38 Cr | ₹-29 Cr | ₹264 Cr | ₹-50 Cr |
| Free Cash Flow | ₹50 Cr | ₹60 Cr | ₹29 Cr | ₹43 Cr | ₹130 Cr | ₹124 Cr | ₹170 Cr | ₹149 Cr |
Shareholding
Promoter 58.39% Institutions 15.08% Public 26.53%
Efficiency & Working Capital
ROCE13.9%
Interest Coverage6
Dividend Payout—
Debtor Days40 d
Inventory Days5 d
Payable Days33 d
Cash Conversion Cycle12 d
Working Capital Days45 d
Shareholding Details
As of 2026-06-30
Promoter58.4%
FII12.3%
DII2.4%
Institutions14.7%
Public26.9%
Promoter Pledge44.5%
No. of Shareholders36,335
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Nov 2025 | Nov 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68% | 67.5% | 67.2% | 67.2% | 67.2% | 66.5% | 66.5% | 58.4% | 58.4% | 58.4% | 58.4% | 58.4% |
| FIIs | 0.1% | 0.2% | 0.2% | 0.6% | 0.3% | 0.2% | 0.4% | 12.5% | 12.5% | 12.5% | 12.2% | 12.3% |
| DIIs | 2.6% | 3.5% | 3.6% | 4.5% | 5% | 4.8% | 4.3% | 3.3% | 3.3% | 2.9% | 2.9% | 2.4% |
| Public | 29.3% | 28.9% | 29% | 27.7% | 27.5% | 28.5% | 28.8% | 19.6% | 25.7% | 26.2% | 26.5% | 26.9% |
| Promoter Pledge | 0% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% | 44.5% |
| No. of Shareholders | 19,993 | 19,795 | 26,054 | 27,003 | 28,397 | 31,614 | 33,559 | 31,884 | 31,884 | 31,602 | 32,044 | 36,335 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Constructive Finance Private Limited | Shareholding of Promoter and Promoter Group | 58.4% | 9.24 Cr |
| International Finance Corporation | Public Shareholding | 12% | 1.90 Cr |
| Governor Of Kerala | Public Shareholding | 4.3% | 67,49,600 |
| Devlina Chakravarty | Public Shareholding | 3% | 46,72,820 |
| Kerala State Industrial Development Corporation | Public Shareholding | 1.9% | 30,00,000 |
| Onkar Kanwar | Shareholding of Promoter and Promoter Group | 0% | 13,850 |
| Taru Kanwar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Raaja Kanwar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sunrays Properties And Investments Company Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Landmark Farms And Housing Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Milers Global Pvt Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Classic Industries And Exports Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ptl Enterprises Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Osk Holdings Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Apollo Tyres Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Polar Energy And Infratech Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Fortune Propmart Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Leto Realtors Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Indian Institute Of Translational Research Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Neeraj Kanwar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shalini Kanwar Chand | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Onkar Kanwar | 0 | 0% | 2026-06-30 |
| Taru Kanwar | 0 | 0% | 2026-06-30 |
| Raaja Kanwar | 0 | 0% | 2026-06-30 |
| Constructive Finance Private Limited | 4.12 Cr | 44.5% | 2026-06-30 |
| Sunrays Properties And Investments Company Private Limited | 0 | 0% | 2026-06-30 |
| Landmark Farms And Housing Private Limited | 0 | 0% | 2026-06-30 |
| Milers Global Pvt Ltd | 0 | 0% | 2026-06-30 |
| Classic Industries And Exports Limited | 0 | 0% | 2026-06-30 |
| Ptl Enterprises Limited | 0 | 0% | 2026-06-30 |
| Osk Holdings Private Limited | 0 | 0% | 2026-06-30 |
| Apollo Tyres Limited | 0 | 0% | 2026-06-30 |
| Polar Energy And Infratech Private Limited | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Shalini Kanwar Chand | Non Executive Director | 2025 |
| Onkar S Kanwar | Chairman (Non-Executive) | 2025 |
| Neeraj Kanwar | Non Executive Director | 2025 |
| Sanjib Sen | Independent Director | 2025 |
| Devlina Chakravarty | Managing Director | 2025 |
| Poonam Makkar. | Company Sec. & Compli. Officer | 2025 |
| Akshay Chudasama | Independent Director | 2025 |
| Pallavi Shroff | Independent Director | 2025 |
| Vinod Rai | Independent Director | 2025 |
| Sunam Sarkar | Non Executive Director | 2025 |
| Tapan Mitra | Additional Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Medical and Healthcare Services | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹738 Cr | 69.6% |
| Outside India | ₹323 Cr | 30.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 70 | 16 | 16 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-10 | Dividend (0.45/- per share) | Final |
| dividend | 2026-07-10 | ₹0.45 (45%) | Final |
| dividend | 2025-07-11 | ₹0.45 (45%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 15 | 0 | 0 | 23 | 15 | 53 |
| 2026 | 15 | 0 | 0 | 7 | 2 | 24 |
| 2026 | 0 | 0 | 0 | 15 | 6 | 21 |
Substantial Acquisitions (SAST)
3 disclosure(s)
Conversion Of Compulsorily Convertible Debentures (ccds)15/11/2025 · 1,89,62,247
Conversion Of Compulsorily Convertible Debentures (ccds)15/11/2025 · —
Pref. Allotment16/05/2024 · —
Company Information
🌐 www.artemishospitals.com ↗
📍 Plot No 14 Sector 20, Dwarka, New Delhi, Delhi, 110075
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search